Literature DB >> 11868045

Spectrum of heart failure in older patients: results from the National Heart Failure project.

Edward P Havranek1, Frederick A Masoudi, Kelly A Westfall, Pam Wolfe, Diana L Ordin, Harlan M Krumholz.   

Abstract

BACKGROUND: The elderly make up the majority of patients with heart failure (HF), but information on this segment of the HF population is lacking because clinical trials typically enroll younger patients and population-based studies lack clinical detail. We sought to describe a contemporary national sample of elderly patients with HF and to examine the sample for age-related trends in clinical characteristics.
METHODS: We studied the charts of 800 Medicare patients per state who were hospitalized with a principal diagnosis of HF between April 1998 and March 1999. There were 34,587 patients in the sample after exclusion of patients who were <65 years old, repeat discharges, discharges to another acute care facility or against medical advice, or receiving long-term hemodialysis.
RESULTS: Comorbidity was common. About one third of patients had chronic obstructive pulmonary disease, about 40% had diabetes, more than half had coronary heart disease, and more than half had a history of hypertension, but comorbidity rates declined with age. Left ventricular ejection fraction was <40% in only 50.4% of patients in whom it was assessed. Associated laboratory abnormalities were relatively constant across the age spectrum, but renal insufficiency was more common with advancing age. The likelihood that patients were in long-term care facilities before admission rose quite steeply with age.
CONCLUSIONS: Elderly patients with HF are a heterogeneous group and appear to differ substantially from patients enrolled in clinical trials. Evidence-based guidance for treatment in the context of multiple comorbid conditions, poor renal function, HF with preserved left ventricular systolic function, and residence in long-term care facilities is urgently needed.

Entities:  

Mesh:

Year:  2002        PMID: 11868045     DOI: 10.1067/mhj.2002.120773

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  54 in total

1.  Polypharmacy and comorbidity in heart failure.

Authors:  Frederick A Masoudi; Harlan M Krumholz
Journal:  BMJ       Date:  2003-09-06

Review 2.  A systematic review of validated methods for identifying heart failure using administrative data.

Authors:  Jane S Saczynski; Susan E Andrade; Leslie R Harrold; Jennifer Tjia; Sarah L Cutrona; Katherine S Dodd; Robert J Goldberg; Jerry H Gurwitz
Journal:  Pharmacoepidemiol Drug Saf       Date:  2012-01       Impact factor: 2.890

3.  Impact of prior admissions on 30-day readmissions in medicare heart failure inpatients.

Authors:  Scott L Hummel; Prashanth Katrapati; Brenda W Gillespie; Anthony C Defranco; Todd M Koelling
Journal:  Mayo Clin Proc       Date:  2014-03-29       Impact factor: 7.616

Review 4.  Cardiac resynchronisation therapy: when the drugs don't work.

Authors:  R A Bleasdale; M P Frenneaux
Journal:  Heart       Date:  2004-12       Impact factor: 5.994

5.  A mobile system for the improvement of heart failure management: Evaluation of a prototype.

Authors:  Sarah C Haynes; Katherine K Kim
Journal:  AMIA Annu Symp Proc       Date:  2018-04-16

Review 6.  Heart failure with preserved ejection fraction in the elderly: scope of the problem.

Authors:  Ken Kaila; Mark J Haykowsky; Richard B Thompson; D Ian Paterson
Journal:  Heart Fail Rev       Date:  2012-09       Impact factor: 4.214

7.  Cardiac resynchronization therapy is effective even in elderly patients with comorbidities.

Authors:  Natália António; Carolina Lourenço; Rogério Teixeira; Fátima Saraiva; Lourenço Coelho; Miguel Ventura; João Cristóvão; Luís Elvas; Lino Gonçalves; Luís A Providência
Journal:  J Interv Card Electrophysiol       Date:  2009-11-25       Impact factor: 1.900

8.  Optimal timing of aortic valve replacement in elderly patients with severe aortic stenosis.

Authors:  Akira Marumoto; Yoshinobu Nakamura; Yuichiro Kishimoto; Munehiro Saiki; Motonobu Nishimura
Journal:  Surg Today       Date:  2013-02-06       Impact factor: 2.549

9.  Disparate Rates of Utilization and Progression to Combined Heart Failure and Chronic Obstructive Pulmonary Disease among Asians and Pacific Islanders in Hawai'i.

Authors:  James Davis; Elizabeth Tam; Deborah Taira
Journal:  Hawaii J Med Public Health       Date:  2016-08

10.  Treatment with Optimal Dose Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Has a Positive Effect on Long-Term Survival in Older Individuals (Aged >70 Years) and Octogenarians with Systolic Heart Failure.

Authors:  Luis Sargento; Andre Vicente Simões; Susana Longo; Nuno Lousada; Roberto Palma Dos Reis
Journal:  Drugs Aging       Date:  2016-09       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.